Its interaction with both VCAM-1 and fibronectin present in the BM triggers MM cell signaling leading to stimulation of their growth involving interleukin-6 (IL-6) [25,31,32], and promoting cell adhesion-mediated drug resistance [33,34]. Here, FN1 is linked to Miyoshi myopathy.